Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL)

Istanbul
Currency in TRY
104.70
+0.30(+0.29%)
Closed
GENIL Scorecard
Full Analysis
Stock has taken a big hit over the last week
Fair Value
Day's Range
100.50106.70
52 wk Range
47.66120.20
Key Statistics
Edit
Bid/Ask
104.60 / 104.70
Prev. Close
104.4
Open
103.5
Day's Range
100.5-106.7
52 wk Range
47.66-120.2
Volume
1.48M
Average Volume (3m)
827.18K
1-Year Change
118.61%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GENIL Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Company Profile

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV for the development of molecule SUL-238 as a treatment for Alzheimer's disease and other neurodegenerative diseases. The company was incorporated in 1997 and is headquartered in Cankaya, Turkey.

Employees
626
Market
Türkiye

Compare GENIL to Peers and Sector

Metrics to compare
GENIL
Peers
Sector
Relationship
P/E Ratio
56.2x17.2x−0.6x
PEG Ratio
0.020.230.00
Price/Book
4.9x1.3x2.6x
Price / LTM Sales
2.8x1.7x3.1x
Upside (Analyst Target)
-20.5%53.6%
Fair Value Upside
Unlock25.6%8.0%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.86
Dividend Yield
1.06%
Industry Median 0.94%
Annualised payout
1.1111
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 08, 2023
EPS / Forecast
0.35 / --
Revenue / Forecast
942.10M / --
EPS Revisions
Last 90 days

People Also Watch

395.00
MPARK
+1.80%
25.420
OYAKC
-3.79%

FAQ

What Is the Gen İlaç ve Sağlık Ürünleri (GENIL) Stock Price Today?

The Gen İlaç ve Sağlık Ürünleri stock price today is 104.70

What Stock Exchange Does Gen İlaç ve Sağlık Ürünleri Trade On?

Gen İlaç ve Sağlık Ürünleri is listed and trades on the Istanbul stock exchange.

What Is the Stock Symbol for Gen İlaç ve Sağlık Ürünleri?

The stock symbol for Gen İlaç ve Sağlık Ürünleri is "GENIL."

Does Gen İlaç ve Sağlık Ürünleri Pay Dividends? What’s The Current Dividend Yield?

The Gen İlaç ve Sağlık Ürünleri dividend yield is 1.06%.

What Is the Gen İlaç ve Sağlık Ürünleri Market Cap?

As of today, Gen İlaç ve Sağlık Ürünleri market cap is 31.41B.

What is Gen İlaç ve Sağlık Ürünleri Earnings Per Share?

The Gen İlaç ve Sağlık Ürünleri EPS is 1.86.

From a Technical Analysis Perspective, Is GENIL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.